MRPL23 and nonpapillary renal cell carcinoma: According to the established cut-off point, a high cytoplasmic immunoreactivity of MRPL23 was observed in 50 (50.51%) ccRCC cases, while the remaining 49 (49.49%) exhibited low expression.